Loading, please wait...
:

product description page

Biomarkers for Alzheimer’s Disease Drug Development - (Hardcover)

Biomarkers for Alzheimer’s Disease Drug Development -  (Hardcover) - image 1 of 1

About this item

This volume aims to build a new generation of experts with a broader understanding of key topics in the Alzheimer’s disease field. Chapters guide readers through innovative approaches to the discovery of novel biomarkers in cerebrospinal fluid, innovation in blood-based biomarkers, a comprehensive overview of magnetic resonance imaging and molecular imaging approaches and their value for developing drugs for Alzheimer’s disease, cutting-edge developments in neuropathology and their relevance for Alzheimer’s disease trials, novel genomic strategies for biomarker development, and related topics including neuropsychological testing and advanced analytical methods.Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.

Authoritative and cutting-edge, Biomarkers for Alzheimer's Disease Drug Development aims to ensure successful results in the further study of this vital field.

Genre: Medical
Series Title: Methods in Molecular Biology
Format: Hardcover
Publisher: Springer Verlag
Language: English
Street Date: March 7, 2018
TCIN: 53646737
UPC: 9781493977031
Item Number (DPCI): 248-77-5891
If the item details above aren’t accurate or complete, we want to know about it. Report incorrect product info.
$139.99
Shipping
not available
Not in stores

Ratings & reviews

Prices, promotions, styles and availability may vary by store & online. See our price match guarantee. See how a store is chosen for you.


*See offer details. Restrictions apply. Pricing, promotions and availability may vary by location and at Target.com.